Amgen to Build Generative AI Models for Novel Human Data Insights and Drug Discovery

	Amgen to Build Generative AI Models for Novel...

Generative AI is transforming drug research and development, enabling new discoveries faster than ever — and Amgen, one of the world’s leading biotechnology companies, is tapping the technology to power its research. Amgen will build AI models trained to analyze one of the world’s largest human datasets on an NVIDIA DGX SuperPOD, a full-stack data Read article >

- View Press Release
- Visit NVIDIA Corporation

Posted: January 8, 2024 | By: Wissen Schwamm

Recent NVIDIA related news.

Unleash the Dragonborn: ‘Elder Scrolls V: Skyrim Special Edition’ Joins GeForce NOW

How Georgia Tech’s AI Makerspace Is Preparing the Future Workforce for AI

Demystifying AI-Assisted Artistry With Adobe Apps Using NVIDIA RTX

NVIDIA AI Foundry Builds Custom Llama 3.1 Generative AI Models for the World’s Enterprises

AI, Go Fetch! New NVIDIA NeMo Retriever Microservices Boost LLM Accuracy and Throughput

+ View more NVIDIA related news +

			More Technical Information Than You Can Handle.

Amgen to Build Generative AI Models for Novel...